148
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

The metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definitions among urbanised black South Africans with established coronary artery disease

, MB BCh, , FSMLT (SA), MSc, PhD, , FRCP, FRCPC, FCP (SA), MMed, PhD & , MA, MSc, MD, FRCP
Pages 6-12 | Published online: 12 Aug 2014

  • Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005, 365: 1415–1428.
  • Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus—provisional report of a WHO consultation. Diabet Med 1998, 15: 539–553.
  • Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999, 16: 442–443.
  • Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285: 2486–2497.
  • Einhorn D, Reaven GM, Cobin RH et al., American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Piact 2003, 9: 237–252.
  • Alberti KG, Zimmet P, Shaw J, for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome—a new worldwide definition. Lancet 2005, 366: 1059–1062.
  • Grundy SM, Brewer HB, Cleeman JI et al., Definition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004, 109: 433–438.
  • Enkhmaa B, Shiwaku K, Anuurad E et al., Prevalence of the metabolic syndrome using the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) and the modified ATP III definitions for Japanese and Mongolians. Clin Chem Acta 2005, 352: 105–113.
  • Lakka HM, Laaksonen DE, Lakka TA et al., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288: 2709–2716.
  • Aquilar-Salinos CA, Rojas R, Gómez-Pérez FJ et al., High prevalence of the metabolic syndrome in Mexico. Arch Med Res 2004, 35: 76–81.
  • Gupta R, Deedwania PC, Gupta A, Rastoqi S, Panwar RB, Kothari K. Prevalence of the metabolic syndrome in an Indian urban population. Cardiology 2004, 97: 257–261.
  • Kraja AT, Hunt SC, Pankow JS et al., An evaluation of the metabolic syndrome in the HyperGEN study. Nutr Metab 2005, 2: 2.
  • Makuyana D, Gomo Z, Munyombwe T, Matinga JA, Hakim JG. Metabolic syndrome disorders in urban black Zimbabweans with type 2 diabetes mellitus. Cent Afr J Med 2004, 50: 24–29.
  • Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanised South African blacks with coronary artery disease. Cardiovasc J S Afr 2006, 17: 50–55.
  • Steyn K, Jooste PL, Bourne L et al., Risk factors for coronary heart disease in the black population of the Cape peninsula. S Afr Med J 1991, 79: 480–485.
  • Price GM, Uauy R, Breeze E et al., Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with greater risk of death. Am J Clin Nutr 2006, 84: 449–460.
  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2005, 25: Suppl 1, S37–S42.
  • DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979, 237: E214–E223.
  • McGuire EAH, Helderman JH, Tobin JD et al., Effects of arterial versus venous sampling on analysis of glucose kinetics. J Appl Physiol 1976, 41: 565–573.
  • Pacini G, Bergman RN. Pacberg: An adaptive program for controlling the blood sugar. Comput Methods Programs Biomed 1983, 16: 13–20.
  • Wing JR, van der Merwe MT, Joffe BI et al., Insulin-mediated glucose disposal in black South Africans with essential hypertension. QJM 1994, 87: 431–436.
  • Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18: 499–502.
  • He Y, Jiang B, Wang J et al., Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 2006, 47: 1588–1594.
  • Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabet Med 2006, 4: 441–444.
  • Lorenzo C, Serrano-Rios M, Martinez-Larrad MT et al., Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 2006, 3: 685–691.
  • Saely CH, Koch L, Schmid F et al., Adult treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 2006, 4: 901–907.
  • Athyros VG, Ganotakis ES, Elisaf M, Mikhailidis DP. The prevalence of the metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definitions. Curr Med Res Opin 2005, 8: 1157–1159.
  • Steyn K, Sliwa K, Hawken S et al., Risk factors associated with myocardial infarction in Africa: The INTERHEART Africa Study. Circulation 2005, 90: 3554–3561.
  • Lee SY, Park HS, Kim DJ et al., Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007, 75: 72–80.
  • Coutinho M, Gerstein HC, Wang Y et al., The relationship between glucose and incident cardiovascular events: a meta regression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 1999, 22: 233–240.
  • Kernan WN, Viscoli CM, Inzucchi SE et al., Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke. Arch Intern Med 2005, 165: 227–233.
  • Bartnik M, Rydén L, Ferrari R et al., on behalf of the Euro Heart Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004, 25: 1880–1890.
  • Stewart S, Wilkinson D, Becker A et al., Mapping the emergence of heart disease in a black, urban population in Africa: the Heart of Soweto Study. Int J Cardiol 2006, 108: 101–108.